Thomas Seufferlein

35.8k total citations · 5 hit papers
413 papers, 13.9k citations indexed

About

Thomas Seufferlein is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Thomas Seufferlein has authored 413 papers receiving a total of 13.9k indexed citations (citations by other indexed papers that have themselves been cited), including 215 papers in Oncology, 108 papers in Molecular Biology and 91 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Thomas Seufferlein's work include Pancreatic and Hepatic Oncology Research (104 papers), Colorectal Cancer Treatments and Studies (68 papers) and Cancer Genomics and Diagnostics (55 papers). Thomas Seufferlein is often cited by papers focused on Pancreatic and Hepatic Oncology Research (104 papers), Colorectal Cancer Treatments and Studies (68 papers) and Cancer Genomics and Diagnostics (55 papers). Thomas Seufferlein collaborates with scholars based in Germany, United States and Belgium. Thomas Seufferlein's co-authors include Enrique Rozengurt, Thomas J. Ettrich, Alexander Kleger, Guido Adler, Joachim P. Spatz, Joseph J.�Y. Sung, Petra G. Boelens, David A. Lieberman, William M. Grady and Ernst J. Kuipers and has published in prestigious journals such as The Lancet, JAMA and Journal of Biological Chemistry.

In The Last Decade

Thomas Seufferlein

390 papers receiving 13.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Colorectal cancer

2015 1.1k citations Thomas Seufferlein et al. profile →
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2015 941 citations Michel Ducreux, Thomas Seufferlein et al. Annals of Oncology profile →
Connections between single-cell biomechanics and human disease states: gastrointestinal cancer and malaria

2004 652 citations Joachim P. Spatz, Thomas Seufferlein et al. profile →
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

2023 190 citations Thierry Conroy, Per Pfeiffer et al. Annals of Oncology profile →
Pancreatic cancer

2025 31 citations Thomas Seufferlein et al. profile →

Peers

Countries citing papers authored by Thomas Seufferlein

Since Specialization

Citations

This map shows the geographic impact of Thomas Seufferlein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Seufferlein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Seufferlein more than expected).

Fields of papers citing papers by Thomas Seufferlein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Seufferlein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Seufferlein. The network helps show where Thomas Seufferlein may publish in the future.

Co-authorship network of co-authors of Thomas Seufferlein

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Seufferlein. A scholar is included among the top collaborators of Thomas Seufferlein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Seufferlein. Thomas Seufferlein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lynch Syndrome in Context of the Updated German S3 Guideline Colorectal Cancer: Implementation of Universal MMR/MSI Testing 2025 ·Oncology Research and Treatment ·Deepak Vangala, Thomas Seufferlein, Robert Hüneburg	1
2	Prognostic value of the CRM-status in pancreatic ductal adenocarcinoma - data from a regional cancer registry 2024 ·BMC Cancer ·(unknown), (unknown), Thomas Seufferlein, Daria B. Kokh, (unknown), Claudia Winzler, (unknown), Waldemar Uhl, Andrea Tannapfel, (unknown)	1
3	Impact of power consumption and power saving for GI endoscopy (power on study) on reducing CO ₂ emissions 2024 ·Gut ·(unknown), (unknown), (unknown), (unknown), (unknown), Benjamin Mayer, Martin C. Müller, Martin Wagner, Thomas Seufferlein, Benjamin Walter	1
4	Endoscopic ultrasound-guided access using a lumen-apposing metal stent for the management of duodenal bleeding in a Roux-en-Y anatomy after gastric bypass 2024 ·Endoscopy ·(unknown), (unknown), Marko Kornmann, Thomas Seufferlein, Martin C. Müller, Martin Wagner, Benjamin Walter	0
5	Pancreatic Cancer: BRCA Targeted Therapy and Beyond 2023 ·Cancers ·Fergus Keane, Catherine O’Connor, Wungki Park, Thomas Seufferlein, Eileen M. O’Reilly	14
6	Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up breakdown → 2023 ·Annals of Oncology ·Thierry Conroy, Per Pfeiffer, Valérie Vilgrain, Ángela Lamarca, Thomas Seufferlein, Eileen M. O’Reilly, Thilo Hackert, Talia Golan, Gerald W. Prager, Karin Haustermans, Arndt Vogel, Michel Ducreux	190
7	TBX3 is dynamically expressed in pancreatic organogenesis and fine-tunes regeneration 2023 ·BMC Biology ·(unknown), Silvia Schirge, Johann Gout, Frank Arnold, (unknown), Ingo Burtscher, (unknown), Medhanie Mulaw, Friedemann Zengerling, Çagatay Güneş, Heiko Lickert, Vincent M. Christoffels, Stefan Liebau, Martin Wagner, Thomas Seufferlein, Christian Bolenz, Anne Moon, Lukas Perkhofer, Alexander Kleger	1
8	DNA methylation‐associated allelic inactivation regulates Keratin 19 gene expression during pancreatic development and carcinogenesis 2023 ·The Journal of Pathology ·Jana Krüger, (unknown), Markus Breunig, (unknown), (unknown), Jessica Merkle, Medhanie Mulaw, (unknown), (unknown), C. Morgenstern, Ninel Azoitei, Thomas Seufferlein, Thomas F.E. Barth, Reiner Siebert, Meike Hohwieler, Alexander Kleger	3
9	Comparative Panel Sequencing of DNA Variants in cf-, ev- and tumorDNA for Pancreatic Ductal Adenocarcinoma Patients 2022 ·Cancers ·(unknown), (unknown), (unknown), (unknown), Johann M. Kraus, (unknown), (unknown), (unknown), Thomas J. Ettrich, Hans A. Kestler, Christoph Kahlert, Thomas Seufferlein, Tim Eiseler	4
10	UEG position paper: Obesity and digestive health 2022 ·United European Gastroenterology Journal ·Patrizia Burra, Marianna Arvanitakis, Jorge Amil Dias, Michael Bretthauer, (unknown), Daniel Hartmann, Patrick Michl, Thomas Seufferlein, Joana Torres, Hans Törnblom, Monique E. van Leerdam, Shira Zelber‐Sagi, (unknown)	4
11	Digestive cancer screening across Europe 2022 ·United European Gastroenterology Journal ·Patrizia Burra, Michael Bretthauer, (unknown), (unknown), Pierluigi Fracasso, Mārcis Leja, (unknown), Patrick Michl, Luigi Ricciardiello, Thomas Seufferlein, Monique E. van Leerdam, (unknown)	10
12	Microbial Spectra and Clinical Outcomes from Endoscopically Drained Pancreatic Fluid Collections: A Descriptive Cohort Study 2022 ·Antibiotics ·(unknown), Benjamin Walter, (unknown), Frank Arnold, Thomas Seufferlein, Martin Wagner, Martin C. Müller, Alexander Kleger	3
13	Platinum-Based Chemotherapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: Summary of Evidence and Application in Clinical Practice 2022 ·Oncology Research and Treatment ·Anke Reinacher‐Schick, Dirk Arnold, Marino Venerito, Eray Goekkurt, (unknown), Thomas Seufferlein	1
14	Pancreatic Cancer Small Extracellular Vesicles (Exosomes): A Tale of Short- and Long-Distance Communication 2021 ·Cancers ·(unknown), (unknown), Thomas Seufferlein, Tim Eiseler	19
15	Differentiation of human pluripotent stem cells into pancreatic duct-like organoids 2021 ·STAR Protocols ·Markus Breunig, Jessica Merkle, (unknown), Sandra Heller, Thomas Seufferlein, Matthias Meier, Meike Hohwieler, Alexander Kleger	10
16	CDKN2A-Mutated Pancreatic Ductal Organoids from Induced Pluripotent Stem Cells to Model a Cancer Predisposition Syndrome 2021 ·Cancers ·Jessica Merkle, Markus Breunig, (unknown), (unknown), Jana Krüger, (unknown), Susanne Bens, Reiner Siebert, Lukas Perkhofer, Ninel Azoitei, Thomas Seufferlein, Sandra Heller, Matthias Meier, Martin C. Müller, Alexander Kleger, Meike Hohwieler	15
17	Smartphone Application to Reinforce Education Increases High-Quality Preparation for Colorectal Cancer Screening Colonoscopies in a Randomized Trial 2020 ·Clinical Gastroenterology and Hepatology ·Benjamin Walter, (unknown), Leopold Ludwig, Nektarios Dikopoulos, Martina Mayr, Bruno Neu, Benjamin Mayer, Alexander Hann, Benjamin Meier, Karel Caca, Thomas Seufferlein, Alexander Meining	26
18	An Immunological Glance on Pancreatic Ductal Adenocarcinoma 2020 ·International Journal of Molecular Sciences ·(unknown), Frank Arnold, (unknown), Friedemann Zengerling, Ninel Azoitei, Thomas Seufferlein, Christian Bolenz, Alexander Kleger	13
19	HSP90 Supports Tumor Growth and Angiogenesis through PRKD2 Protein Stabilization 2014 ·Cancer Research ·Ninel Azoitei, Kristina Diepold, Cornelia Brunner, A. MAUREEN ROUHI, Felicitas Genze, Alexander Becher, Hans A. Kestler, Johan Van Lint, Gabriela Chiosis, John Koren, Stefan Fröhling, Claudia Scholl, Thomas Seufferlein	51
20	Correction: Impact of Tumor Cell Cytoskeleton Organization on Invasiveness and Migration: A Microchannel-Based Approach 2010 ·PLoS ONE ·Claudio G. Rolli, Thomas Seufferlein, Ralf Kemkemer, Joachim P. Spatz	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact